Special Issue on Childhood Asthma

Submission Deadline: Apr. 10, 2020

Please click the link to know more about Manuscript Preparation: http://www.ajpediatrics.org/submission

This special issue currently is open for paper submission and guest editor application.

Please download to know all details of the Special Issue

Special Issue Flyer (PDF)
  • Lead Guest Editor
    • Andrew Kiboneka
      Department of Paediatrics, University of Namibia, Windhoek, Khomas Region, Namibia
  • Guest Editor
    Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to complete the Guest Editor application.
    • Ezekiel Mupere
      Makerere Univesity College Of Health Sciences, Mulago Hill, Kampala, Uganda
    • Hellen Aanyu-Tukamuhebwa
      Mulago Hospital, Mulago, Kampala, Uganda
    • Eric Wobudeya
      Mulago Hospital, Mulago, Kampala, Uganda
    • Rebecca Nantanda
      Lung Institute, Makerere University College of Health Sciences, Kampala, Uganda
    • Dan Kibiuule
      Universiy of Namibia, Windhoek, Khomas Region, Namibia
    • Phillip Odonkor
      University Of Namibia, Windhoek, Khomas Region, Namibia
  • Introduction

    Asthma is a rising significant global public health burden especially in the developing countries. The annual prevalence of severe asthma episodes is estimated from 1% to 21% for adults and over 20% for children aged 6–7 years. The prevalence of asthma varies widely around the world, ranging from 0.2% to 21.0% in adults and from 2.8% to 37.6% in 6- to 7-year-old children. The International Study of Asthma and Allergies in Children (ISAAC) reports a significant increase in the global prevalence of asthmatic episodes among children. In Namibia a prevalence of 11.2 % has been reported in adult populations.
    This increase in reporting of asthmatic episodes possibly reflects a greater awareness of Asthma. Similarly, the increase asthmatic episodes, morbidity and mortality among populations in Africa, Latin America and parts of Asia is a rising public health concern.
    Asthma is a chronic inflammatory disease of the conducting airways in which many cells of the innate and adaptive immune systems act together with epithelial cells to cause bronchial hyper-reactivity (BHR) (the tendency of smooth muscle cells in people with asthma to react to various stimuli.
    Nevertheless, the developments of new asthma phenotyping and treatment including machine learning and big data have markedly improved treatment outcomes. In particular, the reclassification of severity of asthma as well as novel treatment options based on immunological biomarkers has improved outcomes among patients with severe asthma in developed countries. However, the integration of immunological interventions a mentioned above in asthma standard international treatment guidelines of developing countries remains limited or unknown. This may compromise the quality of asthma care received by this population and lead to sub-optimal outcomes particularly among patients with severe asthma in both children and adults.
    Understanding heterogeneity in severe asthma at the molecular level and identifying biomarkers characterizing subgroups are essential to developing new, targeted therapies and to selecting patients most likely to respond to these therapies.

    Aims and Scope:

    1. Asthma syndrome
    2. Biomarkers
    3. TH2 High
    4. TH2 low
    5. Heterogeneous Phenotypes
    6. Endo-types
    7. Machine learning
    8. Asthma signatures
    9. Microarray analysis
    10. biological therapy
    11. Thermo-bronchoplasty

  • Guidelines for Submission

    Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.

    Papers should be formatted according to the guidelines for authors (see: http://www.ajpediatrics.org/submission). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.

  • Published Papers

    The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.